Snowball logo
logo
Q1UE

Quest Diagnostics Incorporated

Q1UE34 โ€ข SA
R$613.80+R$26.16ย  (4.45%)
Estimate
P/E
25.5
EPS
24.03
Beta
0.548
Growth
Revenue, YoY
468.92%
Net income, YoY
485.76%
FCF, YoY
0.03%
Dividends
Dividend yield
5.17%
Annual payout
$6.12
Next ex. div date
October 7, 26
Payout
76.47%
Dividend growth streak
1 year
Div.rating
About the company
Ticker
Q1UE34
ISIN
Country
United States of America
Sector (GICS)
Other
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Frequently asked questions

What sector does Quest Diagnostics Incorporated (Q1UE34) operate in?

Quest Diagnostics Incorporated belongs to the Other sector and operates in the Diagnostics & Research industry.

What is Quest Diagnostics Incorporated (Q1UE34) current stock price?

As of the latest data, Quest Diagnostics Incorporated stock price is R$613.80, with a previous close of R$587.64. Quest Diagnostics Incorporated gained R$26.16 in the last trading session, representing a 4.45% increase.

What is Quest Diagnostics Incorporated (Q1UE34) current market capitalization?

Quest Diagnostics Incorporated market cap is approximately 135.49 billion.

What is Quest Diagnostics Incorporated (Q1UE34) Earnings Per Share (EPS)?

The trailing EPS is R$24.03.

What is Quest Diagnostics Incorporated (Q1UE34) Price-to-Earnings (P/E) ratio?

Quest Diagnostics Incorporated current P/E ratio is 25.54.

Does Quest Diagnostics Incorporated (Q1UE34) pay dividends?

Yes. Quest Diagnostics Incorporated pays quarterly dividends with an annualized yield of 5.17% and an estimated annual payout of R$6.12 per share.

When is the next ex-dividend date for Quest Diagnostics Incorporated (Q1UE34)?

The next ex-dividend date is scheduled for October 07, 2026.

What is Quest Diagnostics Incorporated (Q1UE34) beta (volatility) score?

Quest Diagnostics Incorporated has a beta of 0.548, indicating lower volatility than the overall market.